Literature DB >> 26573607

Estimation of cancer burden in Guangdong Province, China in 2009.

Su-Mei Cao1,2, Yan-Jun Xu3, Guo-Zhen Lin4, Qi-Hong Huang5, Kuang-Rong Wei6, Shang-Hang Xie7,8, Qing Liu9,10.   

Abstract

BACKGROUND: Surveying regional cancer incidence and mortality provides significant data that can assist in making health policy for local areas; however, the province- and region-based cancer burden in China is seldom reported. In this study, we estimated cancer incidence and mortality in Guangdong Province, China and presented basic information for making policies related to health resource allocation and disease control.
METHODS: A log-linear model was used to calculate the sex-, age-, and registry-specific ratios of incidence to mortality (I/M) based on cancer registry data from Guangzhou, Zhongshan, and Sihui between 2004 and 2008. The cancer incidences in 2009 were then estimated according to representative I/M ratios and the mortality records from eight death surveillance sites in Guangdong Province. The cancer incidences in each city were estimated by the corresponding sex- and age-specific incidences from cancer registries or death surveillance sites in each area. Finally, the total and region-based cancer incidences and mortalities for the entire population of Guangdong Province were summarized.
RESULTS: The estimated I/M ratios in Guangzhou (3.658), Zhongshan (2.153), and Sihui (1.527) were significantly different (P < 0.001), with an average I/M ratio of 2.446. Significant differences in the estimated I/M ratios were observed between distinct age groups and the three cancer registries. The estimated I/M ratio in females was significantly higher than that in males (2.864 vs. 2.027, P < 0.001). It was estimated that there were 163,376 new cancer cases (99,689 males and 63,687 females) in 2009; it was further estimated that 115,049 people (75,054 males and 39,995 females) died from cancer in Guangdong Province in 2009. The estimated crude and age-standardized rate of incidences (ASRI) in Guangdong Province were 231.34 and 246.87 per 100,000 males, respectively, and 156.98 and 163.57 per 100,000 females, respectively. The estimated crude and age-standardized rate of mortalities (ASRM) in Guangdong Province were 174.17 and 187.46 per 100,000 males, respectively, and 98.59 and 102.00 per 100,000 females, respectively. In comparison with the western area and the northern mountain area, higher ASRI and ASRM were recorded in the Pearl River Delta area and the eastern area in both males and females.
CONCLUSIONS: Cancer imposes a heavy disease burden, and cancer patterns are unevenly distributed throughout Guangdong Province. More health resources should be allocated to cancer control, especially in the western and northern mountain areas.

Entities:  

Mesh:

Year:  2015        PMID: 26573607      PMCID: PMC4647496          DOI: 10.1186/s40880-015-0060-4

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


Background

Cancer is the leading cause of death in China [1-4]. Analyzing the cancer burden in a population can provide valuable information for collecting etiological data and developing cancer control policies. In China, social and economic changes and an aging population have contributed to rapid increases in the morbidity and mortality of most cancers. It has been observed that different provinces/areas in China have uneven trends in cancer development because of special risk factors [5, 6]. Thus, surveying regional cancer incidence and mortality trends can provide valuable data to assist in making health policy for local areas. The National Central Cancer Registry has published Chinese national cancer incidence and mortality statistics since 2008 [7]; however, the province- and region-based cancer burden is rarely reported. Guangdong Province has a highly developed economy and a population of approximately 100 million; however, the level of economic development varies throughout the province. The Pearl River Delta area (including Guangzhou, Shenzhen, Zhuhai, Foshan, Zhongshan, Dongguan, Huizhou, Zhaoqing, and Jiangmen), which is a floodplain in the center of Guangdong Province, and the eastern area (including Shantou, Chaozhou, Jieyang, and Shanwei) of Guangdong Province are economically well developed (i.e., average income), industrialized, populous, and polluted. In comparison, in the northern mountain area (including Shaoguan, Qingyuan, Meizhou, Heyuan, and Yunfu) and the western area (including Zhanjiang, Maoming, and Yangjiang) of the province, the level of economic development is lower, and the population is sparse, but the environmental pollution is lower. Differences in population, economy, industrialization, and lifestyle in various areas of Guangdong Province may influence the risk of cancer. No provincial cancer incidence data exist for Guangdong Province up to now, which limits the evidence available for making cancer control policies. Since 1997, four cancer registry sites have been established in Guangdong Province. These sites cover a population of approximately 20 million, including two big cities (Guangzhou and Shenzhen) and two medium-sized cities (Zhongshan and Sihui); however, these cities are concentrated in the Pearl River Delta area. The uneven distribution of cancer registry sites means that the cancer registry data cannot depict a representative picture of the provincial cancer burden. Recently, three new cancer registry sites were built in Guangdong Province, but they lack precision and completeness with the cancer incidence too low or the incidence-to-mortality (I/M) ratio extremely high. Fortunately, eight death surveillance sites in Guangdong Province are distributed in more areas, including the northern mountain, western, and eastern areas of the province. Estimating the incidence and mortality of cancer using combined data from the cancer registries and death surveillance sites in Guangdong Province will provide more accurate data. Jensen et al. [8] developed a statistical technique for estimating the incidence of cancer using mortality data. They used a model of mortality as a Poisson regression with the log incidence as an offset to estimate the incidence of cancer based on the number of cancer deaths. This model has been applied comprehensively to estimate the cancer burden in European and other countries [2, 9, 10]. Chen et al. [11] used a generalization of this method to estimate the cancer burden in China. They fitted generalized linear mixed models and estimated the parameters of models by a Bayesian Markov chain Monte Carlo method. In the present study, we estimated the total and regional cancer burden in Guangdong Province in 2009 using aggregate data from the cancer registry and death surveillance sites.

Methods

Data source

Incidence and mortality

Since 1997, four cancer registry sites have existed in Guangzhou, Shenzhen, Zhongshan, and Sihui in Guangdong Province. We collected incidence and mortality data between 2004 and 2008 from each registry site. After evaluating the quality of the cancer registries according to the standards defined by the International Agency for Research on Cancer [12], we determined that the completeness and reliability of mortality data from Shenzhen did not meet the standards; therefore, the data from Shenzhen were excluded from the development of an estimation model for the I/M ratio. Thus, data from three cancer registries were included in the estimation model. The reported cancer spectrum in the cancer registries contained all types of cancer (ICD-10 C00-C90). Cancer mortality data were collected from the Guangdong Provincial Center of Disease Control and Prevention. The data were from eight death surveillance sites in Guangdong Province, located in the Yuexiu district of Guangzhou, Zhuhai, Taishan, Nanxiong, Yunfu, Shanwei, Sihui, and Wuhua. The mortality data from Yuexiu of Guangzhou and Sihui overlapped the data from the cancer registries. Therefore, only one set of data was included in the analysis (Table 1).
Table 1

The economic partitions and covered areas of the cancer registry and death surveillance data sources in Guangdong Province, China

Economic areaCityCancer registryDeath surveillance site
Pearl River DeltaGuangzhouGuangzhou
ShenzhenShenzhen
ZhuhaiZhuhai
FoshanZhongshan
ZhongshanZhongshan
DongguanZhongshan
HuizhouZhongshan
ZhaoqingSihui
JiangmenTaishan
EasternShantouShanwei
ChaozhouShanwei
JieyangShanwei
ShanweiShanwei
WesternZhanjiangYunfu
MaomingYunfu
YangjiangTaishan
Northern mountainShaoguanNanxiong
QingyuanNanxiong
MeizhouNanxiong
HeyuanNanxiong
YunfuYunfu
The economic partitions and covered areas of the cancer registry and death surveillance data sources in Guangdong Province, China

Population data

Population and age distribution data were obtained from the Guangdong statistics annual report, published by the Guangdong Statistics Bureau [13]. The estimated provincial population in 2009 was 83,659,800, including 43,091,000 males and 40,568,800 females. Regional population data in 2009 were extracted by sex and age (grouped into 5-year age ranges, e.g., 0–4, 5–9, 10–14, … 80–84, and 85+ years). The estimated populations were 29,670,200 in the Pearl River Delta area, 17,583,400 in the eastern area, 17,741,200 in the western area, and 18,665,000 in the northern mountain area [13].

Statistical methods

Since the I/M ratio is a fairly stable value in a large, defined population, it is used as an index to evaluate the quality of cancer registry data. Furthermore, it can be used to estimate cancer incidence and mortality for the same population [10, 11]. In our study, we estimated cancer incidence in different parts of Guangdong Province using the combination of mortality and the I/M ratio. The I/M ratios were estimated from log-linear models of the number of incident cases based on the aggregation of cancer registries in Guangzhou, Zhongshan, and Sihui between 2004 and 2008, offset by the number of deaths in the same registries and adjusted for sex and age. The regional incidence number (IN) in 2009 were obtained by applying a set of sex-, age-, city-specific I/M ratios and the estimated regional mortality number (MN) as follows: IN = MN × (I/M). Before aggregation, each registry was weighted to account for the relative size of the population. A log-linear regression model was developed for each sex. The age groups were indexed by i (i = 1, …, 18), and the registries were indexed by j (j = 1, 2, 3). The I/M ratio was expressed as the , where βi represents the log of the mean age-specific I/M ratio, and μj represents the random intercept for different registries. Then, the regional incidence was estimated by using the formula exp (μj + βi) × mortality in each age group in each area. For each city in Guangdong Province that was studied, the number of cancer cases and deaths in 2009 were estimated by multiplying the predicted incidence and mortality by the corresponding city populations. The cancer registry and death surveillance sources for the estimated incidences and mortalities in the cities in Guangdong are listed in Table 1. The rates were calculated by using the age-standardized rate per 100,000, based on the standard population of China in 2000. We were authorized to use the data from the cancer registry and death surveillance sites for this analysis. No personal information, such as name, identification number, home address, and personal contact details, was included when the analyzed data were extracted from the database. Given the highly aggregated form of data extraction, ethics approval was not required for this study.

Results

The I/M ratios for cancers in Guangdong Province

Based on the cancer incidence and mortality data from the three cancer registries (Guangzhou, Zhongshan, and Sihui) between 2004 and 2008, the estimated average I/M ratio was 2.446 [95% confidence interval (CI) 2.324–2.568]. The sex- and registry site-adjusted I/M ratios are shown in Table 2. Males had a lower I/M ratio than females (2.027, 95% CI 1.856–2.199 in males and 2.864, 95% CI 2.691–3.038 in females). The I/M ratio in Guangzhou (3.658, 95% CI 3.457–3.859) was the highest; the I/M ratio in Sihui (1.527, 95% CI 1.294–1.759) was the lowest. The age-specific I/M ratio showed an overall declining trend in males and females (Fig. 1); however, the age-specific I/M ratio in males reached a plateau after the 55- to 60-year age range and approached the level of I/M ratio in females.
Table 2

The I/M ratios from the three cancer registries in Guangzhou, Zhongshan, and Sihui in Guangdong Province, China in 2004–2008

VariableMeanStandard deviation95% confidence interval
Sex
 Male2.0270.0871.856–2.199
 Female2.8640.0882.691–3.038
City
 Guangzhou3.6580.1023.457–3.859
 Zhongshan2.1530.1011.953–2.352
 Sihui1.5270.1181.294–1.759
Average2.4460.0622.324–2.568
Fig. 1

The estimated age-specific ratios of cancer incidence to mortality in males and females in three cities (Guangzhou, Zhongshan, and Sihui) using a log-linear regression model in Guangdong Province, China. °, mean of ratio; , 95% confidence interval

The I/M ratios from the three cancer registries in Guangzhou, Zhongshan, and Sihui in Guangdong Province, China in 2004–2008 The estimated age-specific ratios of cancer incidence to mortality in males and females in three cities (Guangzhou, Zhongshan, and Sihui) using a log-linear regression model in Guangdong Province, China. °, mean of ratio; , 95% confidence interval Table 3 shows the I/M ratios of cancers in the three cities in 2009. A log-linear regression model was used to estimate the corresponding cancer incidences in six cities (Zhuhai, Taishan, Nanxiong, Wuhua, Shanwei, and Yunfu) by using the local death surveillance data and the I/M ratios from Sihui or Zhongshan (Table 4).
Table 3

The I/M ratio in Guangzhou, Zhongshan, and Sihui, China in 2009 (per 100,000)

CityMalesFemales
CIARSICMASRMI/MCRASRICMASRMI/M
Guangzhou355.86273.87252.81188.301.41301.64213.48155.6198.381.94
Zhongshan243.47207.74176.01150.221.38156.78122.4780.4361.191.95
Sihui266.38284.30189.26203.181.41190.09164.6599.5082.371.91

CI crude incidence, ASRI age-standardized rate of incidence, CM crude mortality, ASRM age-standardized rate of mortality

Table 4

The mortalities and estimated incidences of cancers in Zhuhai, Taishan, Nanxiong, Wuhua, Shanwei, and Yunfu in Guangdong Province, China in 2009 (per 100,000)

CityMalesFemales
CRASRICMASRMCRASRICMASRM
Zhuhaia 129.88138.5498.65104.49123.12128.7766.1568.42
Taishana 200.34160.82151.87116.04127.77109.9266.8152.09
Nanxiongb 180.63182.25147.96148.80118.20102.6278.4363.39
Wuhuab 162.54178.94134.80146.4289.6294.7061.7162.32
Shanweia 194.89270.15152.64209.99117.65158.8074.0291.38
Yunfub 159.23189.31133.60158.73109.95103.6977.0967.77

Abbreviations as in Table 3

aThe incidence was estimated using the I/M ratio of Zhongshan

bThe incidence was estimated using with the I/M ratio of Sihui

The I/M ratio in Guangzhou, Zhongshan, and Sihui, China in 2009 (per 100,000) CI crude incidence, ASRI age-standardized rate of incidence, CM crude mortality, ASRM age-standardized rate of mortality The mortalities and estimated incidences of cancers in Zhuhai, Taishan, Nanxiong, Wuhua, Shanwei, and Yunfu in Guangdong Province, China in 2009 (per 100,000) Abbreviations as in Table 3 aThe incidence was estimated using the I/M ratio of Zhongshan bThe incidence was estimated using with the I/M ratio of Sihui

Estimated cancer incidence and mortality in Guangdong Province

Cancer incidence data from three cancer registries and cancer mortality data from six death surveillance sites were used to estimate the cancer incidences of the 21 cities in Guangdong Province and then to aggregate the cancer burden in the four economic areas and in the entire province. The cancer incidences in the four areas and the entire Guangdong Province in 2009 are shown in Table 5. The estimated total new cases of cancer in 2009 was 163,376, including 60,352 in the Pearl River Delta area, 39,796 in the eastern area, 30,679 in the western area, and 32,550 in the northern mountain area. The estimated crude incidence and age-standardized rate of incidence (ASRI) of cancer were 231.34 and 246.87 per 100,000 males, respectively, and 156.98 and 163.57 per 100,000 females, respectively. In the four economic areas of Guangdong Province, the ASRI in males was the highest in the eastern area (307.29 per 100,000), followed by the Pearl River Delta area (269.04 per 100,000) and the western area (212.51 per 100,000); it was the lowest in the northern mountain area (206.19 per 100,000). In comparison, the highest ASRI of cancer in females was 208.81 per 100,000 in the Pearl River Delta area, followed by 192.26 per 100,000 in the eastern area, 120.39 per 100,000 in the western area, and 115.25 per 100,000 in the northern mountain area.
Table 5

The estimated incidences of cancers in different economic areas of Guangdong Province, China in 2009 (per 100,000)

AgePearl River Delta areaEastern areaWestern areaNorthern mountain areaTotal
MalesFemalesMalesFemalesMalesFemalesMalesFemalesMalesFemales
0–13.1211.420.000.001.520.0022.3316.339.897.52
5–11.104.8314.440.003.000.006.070.008.451.29
10–9.318.874.9918.031.131.2811.444.736.298.83
15–16.1114.1743.480.0012.993.3212.1513.0721.327.85
20–20.9520.9820.210.0018.473.4916.775.0319.6811.15
25–31.5533.290.0025.2013.0663.4020.2228.2420.4735.80
30–43.7059.6834.9222.6477.8428.9345.2739.5148.4243.69
35–100.40121.47144.97194.75108.4066.72127.0266.20115.16113.35
40–199.18215.82148.5388.37112.35211.18187.21102.58171.00164.52
45–261.48285.85310.2988.25245.70120.84282.85195.39273.03191.04
50–495.54430.46549.58618.31355.78220.15324.67191.34433.34366.45
55–844.85609.30970.50793.85534.70371.16577.29332.40734.95534.29
60–909.10551.381332.26318.87661.70124.18690.18279.68880.88347.81
65–1126.07610.511290.79500.86603.24241.37756.13347.44916.73430.15
70–1440.00879.271726.85611.401466.52405.041278.88471.721457.02601.42
75–1621.16899.101847.731274.011719.95914.12970.90577.311513.55882.38
80–1785.34981.551498.501085.431829.40946.54899.74495.861514.33858.71
85–1643.92730.28673.23491.75661.96525.41414.23392.00852.96541.65
Total221.16185.01276.29174.36215.33125.00221.12124.79231.34156.98
ASRI269.04208.81307.29192.26212.51120.39206.19115.25246.87163.57

ASRI age-standardized rate of incidence

The estimated incidences of cancers in different economic areas of Guangdong Province, China in 2009 (per 100,000) ASRI age-standardized rate of incidence Table 6 shows the estimated crude mortality and age-standardized rate of mortality (ASRM) of cancer in the four economic areas and in the entire Guangdong Province in 2009, including 37,539 in the Pearl River Delta area, 28,566 in the eastern area, 23,857 in the western area, and 25,088 in the northern mountain area. It was estimated that 115,049 people died from cancer in Guangdong in 2009. The crude mortality and ASRM were 174.17 and 187.46 per 100,000 males, respectively, and 98.59 and 102.00 per 100,000 females, respectively. Just like the distribution of cancer incidence, the ASRM of cancer in males was the highest in the eastern area of the province (238.69 per 100,000), but the ASRM of cancer in the Pearl River Delta area was close to that in other areas, with 177.98 per 100,000 in the delta area, 170.55 per 100,000 in the western area, and 168.91 per 100,000 in the northern mountain area. The highest ASRM of cancer in females was 126.78 per 100,000 in the Pearl River Delta area, followed by 113.75 per 100,000 in the eastern area, 79.36 per 100,000 in the western area, and 75.15 per 100,000 in the northern mountain area.
Table 6

The estimated mortalities of cancers in different economic areas of Guangdong Province, China in 2009 (per 100,000)

AgePearl River Delta areaEastern areaWestern areaNorthern mountain areaTotal
MalesFemalesMalesFemalesMalesFemalesMalesFemalesMalesFemales
0–5.216.800.000.000.750.0016.748.996.094.29
5–5.673.638.400.001.750.004.820.995.031.21
10–8.457.804.605.411.040.399.083.555.454.32
15–5.826.2519.870.007.770.7010.987.3810.903.62
20–6.198.798.300.009.311.4110.803.467.914.88
25–9.2615.720.005.805.6621.3311.2011.947.2214.02
30–20.8129.9718.365.9747.449.8531.6815.7627.0619.35
35–47.0152.9475.1559.7963.7828.7788.8829.7163.5144.92
40–97.1090.7792.6728.4075.2098.83142.9067.68103.0575.23
45–162.91157.63230.2830.77184.6554.72215.7992.11193.4095.53
50–317.51250.32414.08298.40284.21136.06278.0196.07321.12197.83
55–458.97308.95712.36384.62402.50221.60448.14189.66499.05278.86
60–570.33347.891017.34194.23509.0281.79535.89212.79639.45227.67
65–829.67436.281024.43339.64500.55181.18667.70269.46735.36312.09
70–1066.07667.731459.35490.201264.56338.321125.39418.521210.05485.95
75–1426.58704.781787.771226.991664.11882.32939.36482.031427.64782.72
80–1523.39711.601568.151054.711727.52861.73794.34438.301405.02739.10
85–1595.98651.34845.07704.85695.05595.55370.01337.05873.45566.12
Total142.57109.88215.93106.86177.1786.23181.9883.92174.1798.59
ASRM177.98126.78238.69113.75170.5579.38168.9175.15187.46102.00

ASRM age-standardized rate of mortality

The estimated mortalities of cancers in different economic areas of Guangdong Province, China in 2009 (per 100,000) ASRM age-standardized rate of mortality

The age distributions of cancer incidence and mortality

Figure 2 shows the age-specific rates of cancer incidence and mortality curves in Guangdong Province. In males, the age-specific rates of cancer incidence and mortality increased sharply after 30 years of age and reached a peak at 75–80 years of age. In females, the incidence and mortality had two peaks: one minor peaked around age 50–55 years and then declined in the subsequent 5–10 year group ranges; thereafter, cancer incidence and the mortality increased again until age 75–80 years.
Fig. 2

The estimated age-specific rates of cancer incidences and mortalities in males and females using aggregate data from the cancer registry and death surveillance sites in Guangdong Province, China in 2009. IM incidence in males, IF incidence in females, MM mortality in males, MF mortality in females

The estimated age-specific rates of cancer incidences and mortalities in males and females using aggregate data from the cancer registry and death surveillance sites in Guangdong Province, China in 2009. IM incidence in males, IF incidence in females, MM mortality in males, MF mortality in females

Discussion

In this study, we estimated the total I/M ratio of cancers in Guangdong Province in 2009 using a log-linear model based on the aggregation of cancer registry and death surveillance data. The population involved in the cancer registries and death surveillance sites was 12.86 million, encompassing 15.4% of the total population of Guangdong [13]. The death surveillance sites were distributed in all areas of Guangdong, which made the estimation more representative and precise. Owing to the difference in the I/M ratios among different sex and age groups, we also used sex- and age-specific parameters in the model. Therefore, the estimation reflects the realistic cancer burden in Guangdong Province and provides valuable information for developing cancer prevention and control policies. It has been reported that the I/M ratios of cancers differ significantly in different registries, sexes, and age groups [9, 10]. Indeed, our results, based on data from three cancer registry sites, showed that the average I/M ratios in Guangzhou, Zhongshan, and Sihui were clearly distinguished. The I/M ratio in Guangzhou was the highest, followed by Zhongshan; Sihui had the lowest I/M ratio. The estimated I/M ratio was consistent with the regional economic development level and health resources. Guangzhou is the capital of Guangdong Province and congregated high-level general hospitals and tumor hospitals. High quality of health service may result in a higher average I/M ratio in Guangdong (2.466) than in the country as a whole (1.35) [9]. Therefore, the I/M ratio in Guangzhou is not suitable for other cities in Guangdong Province. We used the I/M model of Zhongshan to estimate the cancer incidence in medium-sized cities, such as Zhuhai, Taishan, and Shanwei; we used the I/M model of Sihui to estimate the cancer incidence in other cities. With increasing age from 30 years until 85 years old, the I/M ratio of cancer decreased in both males and females. The trend in females was almost linear; however, there was a plateau in males at 40–60 years of age. The high incidences and mortalities of liver and lung cancer in this age range of males may explain the results. The results showed that the estimated crude cancer incidences in Guangdong Province were 231.34 per 100,000 males and 156.98 per 100,000 females in 2009, with 163,376 new cancer cases occurring annually (99,689 males and 63,687 females). These crude cancer incidences in Guangdong Province are higher than the nationwide average and close to the incidences in urban areas throughout the entire country [9]. According to the areal relationship and economic developing level, Guangdong Province was divided into four economic areas, including the eastern area, the Pearl River Delta area, the western area, and the northern mountain area. We analyzed the cancer incidences and mortalities in these areas. Higher cancer incidence and mortality in males and females were observed in the eastern area and the Pearl River Delta area; lower rates were observed in the western area and the northern mountain area. The higher cancer incidences and mortalities in the eastern area and the Pearl River Delta area may be related to a higher level of urbanization and industrialization, which brought more carcinogenetic contaminants to the environments. From our results, the total numbers of cases and death in the eastern, western, and northern mountain areas accounted for more than 60% of all cancer cases in Guangdong in 2009. At present, cancer treatment resources are focused mainly on the Pearl River Delta area of Guangdong, especially Guangzhou and Shenzhen. This reflected that health resources distributed imbalance in Guangdong Province. We recommend that the allocation of medical resources and cancer treatment levels should be improved in the eastern, western, and northern mountain areas. Our study showed that the estimated age-specific rates of cancer incidences and mortalities in Guangdong Province in 2009 increased monotonically with increasing age in males. However, in females, the age-specific rates of cancer incidences and mortalities had two peaks: one minor peaked around ages 50–55 years and then declined in the subsequent 5–10 year group ranges; thereafter, the cancer incidence and mortality increased again until ages 75–80 years. We suppose that this may be caused by an early exposure to common carcinogenic agents in females. For example, it has been reported that breast cancer, which is one of the most common cancers in Chinese women, has an earlier age of onset in Chinese women compared with women in Western countries [14]. This may be due to lifestyle differences in early life and differences of genetic background [15]. There are some limitations in this study. First, we only focused on the whole cancer burden in the dimension of cancer incidence and mortality and not to explore other dimension, such as cost of cancer treatment. Second, there is usually a 3-year delay in the publication of cancer registry data in China; therefore, we could use the data between 2004 and 2008 only to build the model of I/M ratio estimation and to estimate the incidence in 2009. In the future, more comprehensive and long-term cancer data should be collected, including cancer incidences and mortalities and survival data, so that more detailed and precise cancer burden analysis can be performed.
  13 in total

1.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

2.  Report of cancer incidence and mortality in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou
Journal:  Ann Transl Med       Date:  2014-07

3.  Cancer in the European Community and its member states.

Authors:  O M Jensen; J Estève; H Møller; H Renard
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

Review 4.  The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China.

Authors:  Yize Xiao; Ying Shao; Xianjun Yu; Guangbiao Zhou
Journal:  Front Med       Date:  2012-12-07       Impact factor: 4.592

Review 5.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.

Authors:  D Max Parkin; Freddie Bray
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

6.  [Estimation and prediction on cancer related incidence and mortality in China, 2008].

Authors:  Min Dai; Jian-song Ren; Ni Li; Qian Li; Lin Yang; Yu-heng Chen
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2012-01

7.  Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China.

Authors:  Wei-Hua Jia; Qi-Hong Huang; Jian Liao; Weimin Ye; Y Y Shugart; Qing Liu; Li-Zhen Chen; Yan-Hua Li; Xiao Lin; Fa-Lin Wen; Hans-Olov Adami; Yi Zeng; Yi-Xin Zeng
Journal:  BMC Cancer       Date:  2006-07-06       Impact factor: 4.430

8.  Cancer burden in China: a Bayesian approach.

Authors:  Wanqing Chen; Bruce K Armstrong; Rongshou Zheng; Siwei Zhang; Xueqin Yu; Mark Clements
Journal:  BMC Cancer       Date:  2013-10-06       Impact factor: 4.430

9.  Incidence and mortality of liver cancer in China, 2010.

Authors:  Kuang-Rong Wei; Xia Yu; Rong-Shou Zheng; Xia-Biao Peng; Si-Wei Zhang; Ming-Fang Ji; Zhi-Heng Liang; Zhi-Xiong Ou; Wan-Qing Chen
Journal:  Chin J Cancer       Date:  2014-07-11

10.  The incidences and mortalities of major cancers in China, 2010.

Authors:  Wan-Qing Chen; Rong-Shou Zheng; Si-Wei Zhang; Hong-Mei Zeng; Xiao-Nong Zou
Journal:  Chin J Cancer       Date:  2014-07-11
View more
  11 in total

1.  Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.

Authors:  Yuxiang Ma; Yuehao Lin; Benyan Zou; Wanli Liu; Yang Zhang; Liping Zhao; Yan Huang; Yunpeng Yang; Wenfeng Fang; Yuanyuan Zhao; Jin Sheng; Tao Qin; Zhihuang Hu; Salavatore J Salamone; Yunying Li; Li Zhang; Hongyun Zhao
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

2.  Cancer incidence and mortality in Guangdong province, 2012.

Authors:  Ruilin Meng; Kuangrong Wei; Liang Xia; Yanjun Xu; Wanqing Chen; Rongshou Zheng; Lifeng Lin
Journal:  Chin J Cancer Res       Date:  2016-06       Impact factor: 5.087

3.  A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.

Authors:  Ya-Hui Yu; Wei-Xiong Xia; Jun-Li Shi; Wen-Juan Ma; Yong Li; Yan-Fang Ye; Hu Liang; Liang-Ru Ke; Xing Lv; Jing Yang; Yan-Qun Xiang; Xiang Guo
Journal:  Chin J Cancer       Date:  2016-06-29

Review 4.  Occipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature review.

Authors:  Jing Yang; Wei-Xiong Xia; Yan-Qun Xiang; Xing Lv; Liang-Ru Ke; Ya-Hui Yu; Xiang Guo
Journal:  Chin J Cancer       Date:  2016-01-04

5.  CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.

Authors:  Dong-Fang Meng; Ping Xie; Li-Xia Peng; Rui Sun; Dong-Hua Luo; Qiu-Yan Chen; Xing Lv; Lin Wang; Ming-Yuan Chen; Hai-Qiang Mai; Ling Guo; Xiang Guo; Li-Sheng Zheng; Li Cao; Jun-Ping Yang; Meng-Yao Wang; Yan Mei; Yuan-Yuan Qiang; Zi-Meng Zhang; Jing-Ping Yun; Bi-Jun Huang; Chao-Nan Qian
Journal:  J Exp Clin Cancer Res       Date:  2017-01-28

6.  Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.

Authors:  Yuan-Yuan Qiang; Chang-Zhi Li; Rui Sun; Li-Sheng Zheng; Li-Xia Peng; Jun-Ping Yang; Dong-Fang Meng; Yan-Hong Lang; Yan Mei; Ping Xie; Liang Xu; Yun Cao; Wen-Wen Wei; Li Cao; Hao Hu; Qin Yang; Dong-Hua Luo; Ying-Ying Liang; Bi-Jun Huang; Chao-Nan Qian
Journal:  J Exp Clin Cancer Res       Date:  2018-02-20

7.  Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.

Authors:  Rui-Chen Li; Yong Du; Qiu-Yao Zeng; Lin-Quan Tang; Hua Zhang; Yan Li; Wan-Li Liu; Qian Zhong; Mu-Sheng Zeng; Xiao-Ming Huang
Journal:  Oncotarget       Date:  2016-03-29

8.  PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.

Authors:  Meng-Yao Wang; Zhi-Rui Lin; Yun Cao; Li-Sheng Zheng; Li-Xia Peng; Rui Sun; Dong-Fang Meng; Ping Xie; Jun-Ping Yang; Li Cao; Liang Xu; Bi-Jun Huang; Chao-Nan Qian
Journal:  Oncotarget       Date:  2016-05-03

9.  Effect of relevant factors on radiation-induced nasopharyngeal ulcer in patients with primary nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Authors:  Zhaodong Fei; Taojun Chen; Xiufang Qiu; Chuanben Chen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-02-19

10.  Willingness to Self-Isolate When Facing a Pandemic Risk: Model, Empirical Test, and Policy Recommendations.

Authors:  Xiaojun Zhang; Fanfan Wang; Changwen Zhu; Zhiqiang Wang
Journal:  Int J Environ Res Public Health       Date:  2019-12-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.